56 results match your criteria: "Tokyo Bay Medical Center[Affiliation]"
Cardiovasc Intervent Radiol
March 2023
Department of Cardiology, Tokyo Bay Medical Center, Chiba, Japan.
Purpose: To identify lesion characteristics associated with restenosis after endovascular therapy (EVT) for common femoral artery (CFA) lesions in patients with peripheral artery disease (PAD) in real-world practice.
Materials And Methods: We included 751 Japanese patients with PAD who underwent CFA EVT. Data were from a large-scale retrospective multicenter registry study.
CVIR Endovasc
October 2022
Department of Cardiovascular Medicine, Asahi General Hospital, I-1326 Asahi, Chiba, 289-2511, Japan.
Background: Several studies have reported the efficacy of drug-coated balloons (DCB) for simple femoropopliteal (FP) lesions. However, the effectiveness of DCB for FP chronic total occlusive lesions (CTO) is controversial. The present study investigated the clinical outcomes of DCB for FP-CTO.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
November 2022
Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Purpose: The aim of this preapproval trial was to evaluate the 12-month safety and effectiveness of the TCD-17187 drug-coated balloon (DCB) for the treatment of atherosclerotic lesions in the superficial femoral artery (SFA) and/or proximal popliteal artery (PA).
Methods: This was a prospective, multicenter, core laboratory adjudicated, single-arm trial. From October 2019 to November 2020, a total of 121 symptomatic peripheral artery disease patients with SFA and/or proximal PA lesions were enrolled.
J Endovasc Ther
June 2024
Department of Radiology, Tan Tock Seng Hospital, Singapore.
Purpose: Chronic limb-threatening ischemia (CLTI) represents the clinical end stage of lower extremity peripheral arterial disease (PAD). Although conventional open and endovascular revascularization options are available, some CLTI patients do not respond to these treatments, generally due to small vessel occlusive disease, with only limited or no clinical improvement achieved. This article aims to provide insights related to pertinent venous anatomy of the leg and below the ankle and a technical review of percutaneous deep venous arterialization (pDVA) creation using commonly-available devices.
View Article and Find Full Text PDFCardiovasc Interv Ther
October 2022
Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University, Tokyo, Japan.
JACC Cardiovasc Interv
July 2022
Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
Background: Thromboendarterectomy (TEA) is the gold-standard treatment for common femoral artery (CFA). However, because of its low invasiveness and short hospitalization duration, CFA endovascular therapy (EVT) is performed in real-world practice. However, the clinical benefits and appropriate target population for CFA EVT remain unclear.
View Article and Find Full Text PDFCardiovasc Interv Ther
October 2022
Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University, Tokyo, Japan.
J Cardiovasc Surg (Torino)
October 2022
Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan.
In this review article, we summarize the clinical benefit of intravascular ultrasounds (IVUS) in the endovascular therapy (EVT) of complex femoropopliteal (FP) lesions. Due to the development of novel FP-dedicated devices, outcomes of FP-EVT have been improved. As a result, revascularization methods for the FP lesions have shifted to EVT.
View Article and Find Full Text PDFTher Apher Dial
February 2023
Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
Cardiovasc Intervent Radiol
May 2022
Department of Cardiology, Tokyo Bay Medical Center, 3-4-32, Todaijima, Urayasu, Chiba, 279-0001, Japan.
Purpose: A dedicated treatment strategy is not yet established for patients with no-option chronic limb-threatening ischemia. This study aimed to evaluate the clinical outcomes of percutaneous deep venous arterialization in Japanese patients with no-option chronic limb-threatening ischemia.
Materials And Methods: Data of 18 consecutive patients with chronic limb-threatening ischemia (18 limbs; mean age: 75.
J Endovasc Ther
December 2022
Department of Radiology and IVR Center, Nara Medical University, Kashihara, Japan.
Purpose: To assess the midterm safety and effectiveness of the Gore® Viabahn® Endoprosthesis as treatment for symptomatic peripheral arterial disease (PAD) in the superficial femoral arteries (SFA).
Materials And Methods: A prospective, multicenter, post-market surveillance study was conducted in Japan. Patients with symptomatic SFA lesions ≥ 10 cm and reference vessel diameters ranging from 4.
Int J Surg Case Rep
January 2022
Department of Surgery, Jichi Medical University, Japan. Electronic address:
Introduction And Importance: With the widespread use of laparoscopic inguinal hernia repair, it is known that some clinically evident inguinal hernias lack a peritoneal sac and are referred to as "sacless hernias".
Presentation Of Case: A 61-year-old man presented with a left inguinal bulge. On physical examination, the diagnosis of bilateral inguinal hernias was made, and laparoscopic transabdominal repair was performed.
Catheter Cardiovasc Interv
November 2021
Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
Objective: To investigate the safety and efficacy of a balloon-expandable covered stent in the treatment of complex aortoiliac artery disease.
Background: Peripheral intervention in complex aortoiliac disease still remains a challenge.
Methods: We retrospectively analyzed symptomatic patients with aortoiliac disease who were treated with GORE® VIABAHN® VBX covered stent (W.
J Vasc Surg Cases Innov Tech
September 2021
Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
JRSM Cardiovasc Dis
June 2021
Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
An 86-year-old woman was admitted for a ruptured popliteal artery aneurysm (rPAA, 26 × 28 mm). Due to the patient's age and comorbidities, emergency endovascular repair was performed. After the failed antegrade guidewire crossing, a retrograde approach from the anterior tibial artery and snaring was performed for lesion crossing, and stentgraft (5 × 50 mm) was deployed from antegrade fashion.
View Article and Find Full Text PDFJACC Cardiovasc Interv
May 2021
Department of Radiology, Nara Medical University, Kashihara, Japan.
Objectives: This study sought to elucidate the clinical impact and prognosis of stent graft (SG) thrombosis.
Background: The VIABAHN SG offers a favorable outcome in long peripheral artery occlusive disease (PAOD) lesions in the femoropopliteal artery. One concern after SG deployment is the incidence of stent thrombosis and consequent acute limb ischemia (ALI).
Surg Case Rep
May 2021
Department of Surgery, Tokyo Bay Medical Center, 3-4-32 Todaijima, Urayasu, Chiba, 279-0001, Japan.
Background: Metastatic lesions to the appendix are rare. They usually present with acute appendicitis or remain asymptomatic and are diagnosed incidentally. Metastases to the appendix have been reported from a number of primary tumor sites including ovary, colon, gastric and lung.
View Article and Find Full Text PDFCardiovasc Interv Ther
April 2022
Department of Cardiology, Tokyo Bay Medical Center, 3-4-32, Todaijima, Urayasu, Chiba, 279-0001, Japan.
Stent invagination (SIV) sometimes occurs during interwoven nitinol stent (IWS) placement due to its complex deployment system. It may cause stent malapposition and reduce the minimum stent area. However, the clinical implications of SIV remain unclear.
View Article and Find Full Text PDFInt J Surg Case Rep
February 2021
Department of Surgery, Tokyo Bay Medical Center, 3-4-32 Todaijima, Urayasu, Chiba, 279-0001, Japan. Electronic address:
Introduction And Importance: The majority of gastrointestinal sarcoma is gastrointestinal stromal tumors and intestinal leiomyosarcoma is rare. Small intestinal mesenchymal tumors are often large at diagnosis, and they commonly present with bleeding or intussusception. We report a perforation associated with intestinal leiomyosarcoma.
View Article and Find Full Text PDFCase Rep Emerg Med
October 2020
Department of General Surgery, Tokyo Bay Medical Center, 3-4-32, Todaijima, Urayasu City Chiba 279-0001, Japan.
Background: Over several decades, standard management of blunt spleen injury (BSI) has been changed from operative intervention to the selective operative and nonoperative management (NOM). However, some patient needs laparotomy first. This article describes a case of a BSI patient who failed nonoperative management after angioembolization (AE).
View Article and Find Full Text PDFJ Cardiol Cases
October 2020
Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
A 71-year-old man with symptomatic severe aortic valve stenosis and stenosis of the proximal right coronary artery (RCA) underwent aortic valve replacement with Perceval (LivaNova, London, UK), a sutureless aortic bioprosthesis with a self-expanding open-cell designed nitinol frame (SL-AVR). Seven weeks after the SL-AVR, percutaneous coronary intervention (PCI) to the RCA was required. However, engagement of the guiding catheter (GC) was challenging because the RCA ostium was jailed by the strut of the Perceval.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
November 2020
Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
A severely calcified lesion is the most challenging entity in endovascular therapy (EVT) for below-the-knee (BTK) arteries. In this report, we introduce a challenging plaque modification technique known as the inner PIERCE technique. A 65-year-old man on hemodialysis with multiple toe ulcerations underwent an EVT for his BTK artery diseases.
View Article and Find Full Text PDFJACC Cardiovasc Interv
August 2020
Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.
JACC Cardiovasc Interv
June 2020
Tokyo Bay Medical Center, Urayasu, Japan.